Fat utilization and arterial hypertension in overweight/obese subjects
© Ferro et al.; licensee BioMed Central Ltd. 2013
Received: 8 April 2013
Accepted: 27 June 2013
Published: 2 July 2013
The Respiratory Quotient is a parameter reflecting the utilization of the nutrients by a subject. It is associated with an high rate of subsequent weight gain and with the atherosclerosis. Subjects tending to burn less fat have an increased Respiratory Quotient. Aim of this study was to investigate on the relationship between the Respiratory Quotient and the cardiovascular risk factors.
In this cross-sectional study we enrolled 223 individuals of both sexes aged 45–75 ys that were weight stable, receiving a balanced diet, and not affected by debilitating disease or cardiovascular disease. The Respiratory Quotient was measured by Indirect Calorimetry. The measurement of the Blood Pressure was obtained by a mercury sphygmomanometer.
We enrolled 133 female and 90 male. Systolic blood pressure only was positively correlated to the Respiratory Quotient in univariate and multivariate regression analysis (p=0,017). The prevalence of hypertension was significatively different between the quartiles of the Respiratory Quotient, with the highest prevalence in the IV quartile (p=0,024).
High value of the Respiratory Quotient, an index of nutrients utilization, is associated to an high prevalence of Hypertension. It is possible that in the subjects with high Respiratory Quotient and high body mass index, the activation of the renin angiotensin system, in concert to the reduction of the utilization of the endogenous fat stores, could increase the risk of hypertension.
KeywordsObesity Indirect calorimetry Respiratory Quotient Hypertension
According to the current demographic projections it is expected an increase in the cardiovascular diseases (CVDs) incidence; therefore more sensitive predictors of the risk of the CVDs are needed. In this regard, the Respiratory Quotient (RQ), the ratio between carbon dioxide production and oxygen consumption, reflecting the utilization of the nutrients in a subject  may have an important role. In fact, it is well known that after an overnight fast, a subject receiving a balanced diet, that meets the energy requirements for the weight maintenance, burns fat as main substrate; as consequence the value of RQ, usually, results close to 0.85 [1, 2]. It has been also shown that subjects tending to burn more glucose, but less fat, have an increased value of RQ [3, 4]. Moreover an high RQ is associated with an high rate of subsequent weight gain  and with an increased Carotid Intima-Media Thickness (CIMT), a well known predictor of cardiovascular events , in overweight/obese individuals of both sexes .
At this time, whether RQ is also associated with the cardiovascular risk factors is not fully clarified, therefore aim of this study was to investigate on the relationship between the RQ and the cardiovascular isk factors in individuals of both sexes.
In our cross-sectional study, we consecutively enrolled 223 individuals among a total of 250 evaluated from January 2011 to September 2012, all undergoing the nutritional screening tests including an Indirect Calorimetry for the RQ and Resting Metabolic Rate (RMR) measurement, at our Clinical Nutrition Unit. The population included both gender, having more than 45 years, with a wide range of body mass index (BMI), and participating in the study on the adherence to Mediterranean Diet and body composition (approved by local ethical committee, projects codes 2011.4; 2013-1/CE ). We enrolled subjects who were weight stable in the four weeks preceding the screening tests, who were following a nutritionally balanced diet meeting energy requirements (i.e.: a solid-food diet that supplied 50% of the calories as carbohydrate, 30% as fat, and 20% as protein), as resulted from the nutritional intake assessment.
According to the medical history, physical examination and blood screening tests, we enrolled apparently healthy individuals. We excluded individuals having clinical evidence of debilitating diseases, (cancer, severe renal failure, sever liver insufficiency, chronic obstructive pulmonary disease), thyroid dysfunction, and cardiovascular disease (myocardial infarction, stroke). We excluded also subjects taking antiobesity medications, psychotropic drugs and chronotropic agents. Furthermore, we excluded individuals following who practiced a regular physical exercise program, who had recently changed the use of tobacco (in the previous four months) and smokers. To avoid the presence of individuals with alterations of the pulmonary ventilation we excluded from the statistical analysis, those having an RQ value over 1.00 or under 0.70 (normal range of RQ: 1.00 to 0.70) [7–9]. The following criteria were used to define the distinct cardiovascular risk factors; diabetes: fasting blood glucose ≥126 mg/dl or antidiabetic treatment; hyperlipidemia: total cholesterol >200 mg/dl and/or triglycerides >200 mg/dl or lipid lowering drugs use; hyperuricemia: serum urate concentration > 7 mg/dl or urate lowering drugs use; hypertension: systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg or antihypertensive treatment; overweight: BMI ≥ 25 <30 Kg/m2; obesity: body mass index ≥30 kg/m2; smoking: current smokers or past smokers (at least before the previous four months) [10, 11]. Furthermore, if at least 3 of the NCEP criteria were present , the subjects were identified as having the Metabolic Syndrome (MetS).
All tests were performed after a 12 h overnight fasting. Before tests, we gave no particular suggestions on the menu for the meal, but we requested that the dinner before the experiments would have to include types of foods and drinks usually consumed. Indeed they have no caffeinated beverages between their evening meal and the conclusion of the tests on the examination’s morning. Written informed consent was obtained. The investigation conforms to the principles outlined in the Declaration of Helsinki.
Nutritional intake and anthropometric measurements
The participant’s nutritional intake was calculated using the nutritional software MetaDieta 3.0.1 (Meteda srl, S. Benedetto del Tronto, Italy). Body weight was measured before breakfast with the subjects lightly dressed, subtracting the weight of clothes. Body weight was measured with a calibrated scale and height measured with a wall-mounted stadiometer. BMI was calculated with the following equation: weight (kg) /height (m)2. Waist and hip circumferences (WC and HC) were measured with a nonstretchable tape over the unclothed abdomen at the narrowest point between the costal margin and iliac crest and over light clothing at the level of the widest diameter around the buttocks, respectively, as described in the past . Bioelectrical impedance analysis (BIA) (BIA-101; Akernsrl, Florence, Italy) was performed to estimate the Total Body Water (TBW), Fat Mass (FM), Muscle Mass (MM), and total Fat-Free Mass (FFM) .
Blood pressure measurement
The measurement of the systemic BP of both arms was obtained by a mercury sphygmomanometer(systolic blood pressure - SBP and diastolic blood pressure - DBP) as previously described [14, 15]. Clinic BP was obtained in the supine patients, after 5 min of quiet rest. A minimum of three BP readings were taken using an appropriate BP cuff size (the inflatable part of the BP cuff covered about 80 percent of the circumference of upper arm).
RQ and RMR measurement
Fasting RQ and RMR were measured with the participants in their postabsorptive state in a sedentary position. Respiratory gas exchange was measured by Indirect Calorimetry using the open circuit technique between the hours of 7 AM and 8:30 AM after 48-h abstention from exercise. The Indirect Calorimetry instrument (Viasys Healthcare, Hoechberg, Germany) was used for all measurements. The participant rested quietly for 30 min in an isolated room with temperature controlled (21–24°C) environment. The subject was then placed in a ventilated hood for at least 30 min, until steady state was achieved. Criteria for a valid measurement was a minimum of 15 min of steady state, with steady state determined as less than 10% fluctuation in minute ventilation and oxygen consumption and less than 5% fluctuation in RQ. RQ was calculated as CO2 production/O2 consumption .
Venous blood was collected after fasting overnight into vacutainer tubes (Becton & Dickinson) and centrifuged within 4 h. Serum glucose, creatinine, total cholesterol, high density lipoprotein (HDL)-cholesterol, triglycerides, uric acid were measured with Enzymatic colorimetric test. Quality control was assessed daily for all determinations.
Data are reported as mean ± S.D. The T-test and ANOVA were used to compare the means between groups. The χ 2-test was used to compare the prevalence among the groups. The univariate analysis was used to determine all the factors correlated to the RQ. In this analysis the following factors were included: age, SBP, DBP, BMI, WC, HC, TBW, FM, MM, FFM, RMR, glucose, total cholesterol, triglycerides, HDL-cholesterol, creatinin, uric acid. The multivariate stepwise regression analysis was used to test for confounding variables. In particular, the variables included in this analisys were all that correlated to the RQ at univariate analisys with a p < 0,1 (model I); furthermore, in a second model (model II) we included also the presence of the Metabolic Syndrome (MetS) per sè.
Individuals with incomplete data were excluded from analisys. Significant differences were assumed to be present at P < 0.05. All comparisons were performed using the SPSS 17.0 for Windows (Chicago, USA).
Univariate analysis - factors correlated to RQ
Multivariate analysis – factors correlated to RQ
-Characteristics of the population according to RQ quartiles (means and prevalences)
I RQ quartile (0,78 ± 0,01) (N= 53)
II RQ quartile (0,83 ± 0,01) (N=63)
III RQ quartile (0,87 ± 0,01) (N=48)
IV RQ quartile (0,93 ± 0,02) (N=59)
52 ± 12
53 ± 11
53 ± 11
33 ± 5
31 ± 5
31 ± 4
32 ± 5
1509 ± 252
1433 ± 249
1535 ± 251
1571 ± 352
106 ± 13
102 ± 11
100 ± 8
106 ± 14
109 ± 9
109 ± 10
106 ± 7
111 ± 9
94 ± 25
95 ± 24
95 ± 21
102 ± 34
0,79 ± 0,23
0,76 ± 0,14
0,77 ± 0,2
0,87 ± 0,76
T Cholesterol (mg/dl)
202 ± 45
205 ± 44
208 ± 44
209 ± 52
126 ± 35
127 ± 40
133 ± 41
129 ± 46
53 ± 17
52 ± 12
46 ± 12
50 ± 16
120 ± 59
130 ± 61
163 ± 127
150 ± 83
Uric acid (mg/dl)
5,15 ± 1,60
5,11 ± 1,40
4,95 ± 1,46
123 ± 11
123 ± 15
124 ± 13
130 ± 16
76 ± 7
74 ± 9
75 ± 9
79 ± 9
The main finding of this study was the direct correlation between RQ and SBP and RMR (Table 1) and the high prevalence of hypertension among individuals with the highest RQ (Table 3, Figure 1). After the adjustments for the confounding factors, the RQ remains correlated to SBP.
In particular, subjects with an RQ higher than 0,90 (IV RQ quartile) had an high prevalence of hypertension (47%) unless their metabolic risk profile was similar to that of the other quartiles (i.e. 40% male, mean age ~ 53 ys and mean BMI ~ 32 Kg/m2; tab 3).
This is a novel finding, never investigated to date and very intriguing. It is well known that RQ is associated with a high rate of subsequent weight gain [2, 17]. Indeed the obesity rarely exists as an isolated condition, but it is frequently associated with hypertension . Therefore one possible explanation of the link between the high RQ and hypertension may be a high BMI among the subjects with high RQ, [2, 19], but in our study the similar BMI among quartiles would reject this explanation. Thus, we infer the presence of other mechanisms like the activation of the Renin Angiotensin System (RAS)[19–27], that results to be associated to the mechanisms of lipid oxidation. Several experiments on mice lacking the Angiotensin II receptor showed, in fact, an increase in the fat utilization and a parallel reduction of the fat mass , corroborating the association between hypertension and the index of low fat utilization in our investigation. In addition, a study has shown that in mice with myocardial hypertrophy, the genes associated with the transport and breaking down of the fatty acids are less active than in normal mice . Thus, it is possible to theorize that the failure in the fat utilization may be a predictor of the development of CVDs in individuals with hypertension .
It is well accepted that the cardiovascular risk factors are excellent predictors of the CVDs and that their presence may lead to the abnormalities in the structure and function of the cardiovascular system, by a number of complex mechanisms [11, 30–34].
We believe that, if confirmed by further investigations, also high RQ may have a role in the clinical practice because it has the potential to identify the effect of the modification in the nutrients utilization on the vascular system. Understanding this concept may give a new view on the mechanisms of the organ damage and their prevention and treatment. Consequently, the RQ measurement may contribute to important changes in the prediction of cardiovascular disease. RQ evaluation probably may identify the individuals needing special therapeutic strategies, like individuals with hypertension. However, because our findings were obtained from cross-sectional data, this hypothetical clinical impact can be emphasized but it is not definitely proved. The RQ measurement offers the potential of a fast analyses using a low cost instrument that is easy to use after a short period of training. However, due to the complexity of the various ways in which different diet may be metabolized, actually there is the need to perform the experiments in the same controlled conditions in all individuals (for example, the same diet).
A limitation of this investigation is the cross-sectional nature, thus this study is not able to determine temporality. Furthermore, probably the serum insulin could contribute to help us to better explain our finding but unfortunately in this study this parameter was lacking. The lack of correlation between the parameters of body composition (WC, HC,TBW, FM, MM, FFM) or the presence of MetS with RQ was expected, on the basis of the similar BMI among quartiles. This finding gives strength to our hypothesis, for which the alteration of some mechanisms of fat utilization is linked to RAS and blood pressure and not to obesity or MetS per sè. Of course future studies with a prospective design are needed to clarify the usefulness of the RQ evaluation for the cardiovascular risk stratification and for the prediction of the onset of hypertension.
Carotid intima media thickness
Resting Metabolic Rate
Body mass index
Systolic blood pressure
Diastolic blood pressure.
- Mcneill G, Bruce AC, Ralph A, James WPT: Interindividual differences in fasting nutrient oxidation and the influence of diet composition. Int J Obesity. 1988, 12 (5): 445-463.
- Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C, Ravussin E: Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol Endocrinol Metab. 1990, 259 (5Pt1): E650-E657.
- Schutz Y: Abnormalities of fuel utilization as predisposing to the development of obesity in humans. Obes Res. 1995, 3 (Suppl 2): 173S-178S.View ArticlePubMed
- Schutz Y, Flatt JP, Jequier E: Failure of dietary fat intake to promote fat oxidation: a factor favoring the development of obesity. AJCN. 1989, 50 (2): 307-314.
- Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M: Prediction of clinical cardiovascular events with carotid intima-media thickness—a systematic review and meta-analysis. Circulation. 2007, 115 (4): 459-467. 10.1161/CIRCULATIONAHA.106.628875.View ArticlePubMed
- Montalcini T, Gazzaruso C, Ferro Y, Migliaccio V, Rotundo S, Castagna A, Pujia A: Metabolic fuel utilization and subclinical atherosclerosis in overweight/obese subjects. Endocrine. 2012, Nov 28
- Londeree BR, Ames SA: Trend analysis of the %VO2max—HR regression. Med Sci Sports. 1976, 8 (2): 123-125.PubMed
- Saltin B, Blonquist B, Mitchell RL, Johnson RL, Wildenthal K, Chapman CB: Response to submaximal and maximal exercise after bed rest and training. Circulation. 1968, 38 (Suppl. 7): 1-78.
- Skinner JS, Jankowski LW: Individual variability in the relationship between heart rate and oxygen intake. Med Sci Sports. 1974, 6: 68-72.
- No authors listed. National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension. 1994, 23 (3): 275-285.View Article
- Psaty BM, Furberg CD, Kuller LH, Bild DE, Rautaharju PM, Polak JF, Bovill E, Gottdiener JS: Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med. 1999, 159 (12): 1339-134. 10.1001/archinte.159.12.1339.View ArticlePubMed
- Expert Panel on Detection: Evaluation, and treatment of high blood cholesterol in adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-97. 10.1001/jama.285.19.2486.View Article
- Montalcini T, Gorgone G, Garzaniti A, Gazzaruso C, Pujia A: Artery remodeling and abdominal adiposity in nonobese postmenopausal women. Eur J Clin Nutr. 2010, 64 (9): 1022-1024. 10.1038/ejcn.2010.131.View ArticlePubMed
- Talluri T, Lietdke RJ, Evangelisti A, Talluri J, Maggia G: Fat-free mass qualitative assessment with bioelectric impedance analysis (BIA). Ann NY Acad Sci. 1999, 873: 94-98. 10.1111/j.1749-6632.1999.tb09454.x.View ArticlePubMed
- Montalcini T, Gorgone G, Fava A, Romeo S, Gazzaruso C, Pujia A: Carotid and brachial arterial enlargement in postmenopausal women with hypertension. Menopause. 2012, 19 (2): 145-149. 10.1097/gme.0b013e3182267195.View ArticlePubMed
- Zemel MB, Bruckbauer A: Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects. Nutrients. 2012, 4 (6): 529-541.PubMed CentralView ArticlePubMed
- Seidell JC, Muller DC, Sorkin JD, Andres R: Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore longitudinal study on aging. Int J Obes Relat Metab Disord. 1992, 16 (9): 667-674.PubMed
- Bray GA: Medical consequences of obesity. J Clin Endocrinol Metab. 2004, 89 (6): 2583-2589. 10.1210/jc.2004-0535.View ArticlePubMed
- Salah A, Khan M, Esmail N, Habibullah S, Al LY: Genetic polymorphism of S447X lipoprotein lipase (LPL) and the susceptibility to hypertension. J Crit Care. 2009, 24 (3): 11-14. 10.1016/j.jcrc.2009.06.005.View Article
- Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiéra F, Sharma AM: The adipose-tissue renin–angiotensin–aldosterone system: role in the metabolic syndrome?. Int J Biochem Cell Biol. 2003, 35 (6): 807-825. 10.1016/S1357-2725(02)00311-4.View ArticlePubMed
- Kitajima S, Morimoto M, Liu E, Koike T, Higaki Y, Taura Y, Mamba K, Itamoto K, Watanabe T, Tsutsumi K: Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits. Diabetologia. 2004, 47 (7): 1202-1209.View ArticlePubMed
- Lavie CJ, Milani RV, Ventura HO: Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009, 53 (21): 1925-1932. 10.1016/j.jacc.2008.12.068.View ArticlePubMed
- Rask-Madsen C, Kahn CR: Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2012, 32 (9): 2052-2059. 10.1161/ATVBAHA.111.241919.PubMed CentralView ArticlePubMed
- Saiki A, Koide N, Watanabe F, Murano T, Miyashita Y, Shirai K: Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system. Metabolism. 2008, 57 (8): 1093-10100. 10.1016/j.metabol.2008.03.014.View ArticlePubMed
- Vasan RS: Cardiac function and obesity. Heart. 2003, 89 (10): 1127-1129. 10.1136/heart.89.10.1127.PubMed CentralView ArticlePubMed
- Watkins SJ, Jonker L, Arthur HM: A direct interaction between TGF beta activated kinase 1 and the TGF beta type II receptor: implications for TGF beta signalling and cardiac hypertrophy. Cardiovasc Res. 2006, 69 (2): 432-439. 10.1016/j.cardiores.2005.11.007.View ArticlePubMed
- Zaman AK, Fujii S, Goto D, Furumoto T, Mishima T, Nakai Y, Dong J, Imagawa S, Sobel BE, Kitabatake A: Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. J Mol Cell Cardiol. 2004, 37 (2): 525-53. 10.1016/j.yjmcc.2004.05.006.View ArticlePubMed
- Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P, Quignard-Boulange A: Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes. 2005, 54 (4): 991-9. 10.2337/diabetes.54.4.991.View ArticlePubMed
- Peterson LR, Kelly DP, Gropler RJ, Dàvila-Romàn VG, Herrero P, Delas Fuentes L: Myocardial fatty acid metabolism. Independent predictor of left ventricular mass in hypertensive heart disease. Hypertension. 2003, 41: 83-87. 10.1161/01.HYP.0000047668.48494.39.View ArticlePubMed
- Brummett BH, Babyak MA, Siegler IC, Shanahan M, Harris KM, Elder GH, Williams RB: Systolic blood pressure, socioeconomic status, and biobehavioral risk factors in a nationally representative US young adult sample. Hypertension. 2011, 58 (2): 161-166. 10.1161/HYPERTENSIONAHA.111.171272.PubMed CentralView ArticlePubMed
- Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CD: Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation. 2003, 107 (16): 2089-2095. 10.1161/01.CIR.0000065222.34933.FC.View ArticlePubMed
- Montalcini T, Gorgone G, Gazzaruso C, Garzaniti A, Pujia A: Large Brachial Artery Diameter and Metabolic Syndrome in postmenopausal women. Atherosclerosis. 2010, 210 (2): 458-460. 10.1016/j.atherosclerosis.2009.12.019.View ArticlePubMed
- Montalcini T, Gorgone G, Pujia A: Serum calcium level is related to both intima-media thickness and carotid atherosclerosis: a neglect risk factor in obese/overweight subjects. J Transl Med. 2012, 10: 114-10.1186/1479-5876-10-114.PubMed CentralView ArticlePubMed
- Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97 (18): 1837-1847. 10.1161/01.CIR.97.18.1837.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.